Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Jan, 3 2026
Apr, 26 2025
Jul, 28 2026
May, 7 2026
Jun, 4 2026